Oncology Institute Inc (TOI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oncology Institute Inc (TOI) has a cash flow conversion efficiency ratio of 1.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.63 Million) by net assets ($-12.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oncology Institute Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Oncology Institute Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read TOI current and long-term liabilities for a breakdown of total debt and financial obligations.
Oncology Institute Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oncology Institute Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NOUVEAU MONDE GRAPHITE
F:NM9A
|
N/A |
|
3I Group PLC
LSE:III
|
0.001x |
|
Teqnion AB
ST:TEQ
|
0.105x |
|
Atreyu Capital Markets Ltd
TA:ATRY
|
0.020x |
|
Shanghai Sanmao Enterprise Group Co Ltd A
SHG:600689
|
-0.024x |
|
Alpine Income Property Trust, Inc.
NYSE:PINE
|
0.007x |
|
Transcontinental Inc
TO:TCL-A
|
0.002x |
|
Sam Young Chem
KO:003720
|
0.149x |
Annual Cash Flow Conversion Efficiency for Oncology Institute Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Oncology Institute Inc from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see TOI company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.59 Million | $-26.54 Million | -7.394x | -1061.11% |
| 2023-12-31 | $57.02 Million | $-36.31 Million | -0.637x | -27.02% |
| 2022-12-31 | $123.17 Million | $-61.76 Million | -0.501x | -59.80% |
| 2021-12-31 | $104.16 Million | $-32.68 Million | -0.314x | -1835.57% |
| 2020-12-31 | $28.10 Million | $508.00K | 0.018x | -78.89% |
| 2019-12-31 | $42.22 Million | $3.62 Million | 0.086x | -- |
About Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as education… Read more